Literature DB >> 29987901

Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois.

Noriko Ogasawara1, Aiko I Klingler1, Bruce K Tan2, Julie A Poposki1, Kathryn E Hulse1, Whitney W Stevens1, Anju T Peters1, Leslie C Grammer1, Kevin C Welch2, Stephanie S Smith2, David B Conley2, Robert C Kern1,2, Robert P Schleimer1,2, Atsushi Kato1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29987901      PMCID： PMC6242734          DOI： 10.1111/all.13552

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  9 in total

1.  IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps.

Authors:  Joanne L Shaw; Samer Fakhri; Martin J Citardi; Paul C Porter; David B Corry; Farrah Kheradmand; Yong-Jun Liu; Amber Luong
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

2.  Alternative splicing of interleukin-33 and type 2 inflammation in asthma.

Authors:  Erin D Gordon; Laura J Simpson; Cydney L Rios; Lando Ringel; Marrah E Lachowicz-Scroggins; Michael C Peters; Agata Wesolowska-Andersen; Jeanmarie R Gonzalez; Hannah J MacLeod; Laura S Christian; Shaopeng Yuan; Liam Barry; Prescott G Woodruff; K Mark Ansel; Karl Nocka; Max A Seibold; John V Fahy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

Review 3.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

4.  Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.

Authors:  Whitney W Stevens; Christopher J Ocampo; Sergejs Berdnikovs; Masafumi Sakashita; Mahboobeh Mahdavinia; Lydia Suh; Tetsuji Takabayashi; James E Norton; Kathryn E Hulse; David B Conley; Rakesh K Chandra; Bruce K Tan; Anju T Peters; Leslie C Grammer; Atsushi Kato; Kathleen E Harris; Roderick G Carter; Shigeharu Fujieda; Robert C Kern; Robert P Schleimer
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

5.  Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.

Authors:  Emma Lefrançais; Anais Duval; Emilie Mirey; Stéphane Roga; Eric Espinosa; Corinne Cayrol; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

6.  The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D.

Authors:  Andrea R Teufelberger; Maria Nordengrün; Harald Braun; Tania Maes; Katrien De Grove; Gabriele Holtappels; Clara O'Brien; Sharen Provoost; Hamida Hammad; Amanda Gonçalves; Rudi Beyaert; Wim Declercq; Peter Vandenabeele; Dmitri V Krysko; Barbara M Bröker; Claus Bachert; Olga Krysko
Journal:  J Allergy Clin Immunol       Date:  2017-05-19       Impact factor: 10.793

7.  Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps.

Authors:  Anju T Peters; Atsushi Kato; Ning Zhang; David B Conley; Lydia Suh; Brian Tancowny; Derek Carter; Tara Carr; Michael Radtke; Kathryn E Hulse; Sudarshan Seshadri; Rakesh Chandra; Leslie C Grammer; Kathleen E Harris; Robert Kern; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

8.  Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.

Authors:  Deepti R Nagarkar; Julie A Poposki; Bruce K Tan; Michael R Comeau; Anju T Peters; Kathryn E Hulse; Lydia A Suh; James Norton; Kathleen E Harris; Leslie C Grammer; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2013-05-17       Impact factor: 10.793

9.  Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.

Authors:  Tao Liu; Yoshihide Kanaoka; Nora A Barrett; Chunli Feng; Denise Garofalo; Juying Lai; Kathleen Buchheit; Neil Bhattacharya; Tanya M Laidlaw; Howard R Katz; Joshua A Boyce
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422
  9 in total
  15 in total

Review 1.  The use of biologics for immune modulation in allergic disease.

Authors:  Willem van de Veen; Mübeccel Akdis
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

2.  Sample collection for laboratory-based study of the nasal airway and sinuses: a research compendium.

Authors:  Conner J Massey; Fernando Diaz Del Valle; Waleed M Abuzeid; Joshua M Levy; Sarina Mueller; Corrina G Levine; Stephanie S Smith; Benjamin S Bleier; Vijay R Ramakrishnan
Journal:  Int Forum Allergy Rhinol       Date:  2019-12-17       Impact factor: 3.858

Review 3.  Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes.

Authors:  Ping-Ping Cao; Zhi-Chao Wang; Robert P Schleimer; Zheng Liu
Journal:  Ann Allergy Asthma Immunol       Date:  2018-10-13       Impact factor: 6.347

Review 4.  Group 2 Innate Lymphoid Cells in Airway Diseases.

Authors:  Atsushi Kato
Journal:  Chest       Date:  2019-05-10       Impact factor: 9.410

Review 5.  Mechanisms and pathogenesis of chronic rhinosinusitis.

Authors:  Atsushi Kato; Robert P Schleimer; Benjamin S Bleier
Journal:  J Allergy Clin Immunol       Date:  2022-03-01       Impact factor: 14.290

Review 6.  Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.

Authors:  Tetsuji Takabayashi; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2020-03       Impact factor: 10.793

Review 7.  Group 2 innate lymphoid cells in nasal polyposis.

Authors:  Whitney W Stevens; Atsushi Kato
Journal:  Ann Allergy Asthma Immunol       Date:  2020-08-08       Impact factor: 6.347

8.  Epithelial miR-206 targets CD39/extracellular ATP to upregulate airway IL-25 and TSLP in type 2-high asthma.

Authors:  Kan Zhang; Yuchen Feng; Yuxia Liang; Wenliang Wu; Chenli Chang; Dian Chen; Shengchong Chen; Jiali Gao; Gongqi Chen; Lingling Yi; Dan Cheng; Guohua Zhen
Journal:  JCI Insight       Date:  2021-06-08

Review 9.  Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.

Authors:  Atsushi Kato; Anju T Peters; Whitney W Stevens; Robert P Schleimer; Bruce K Tan; Robert C Kern
Journal:  Allergy       Date:  2021-09-15       Impact factor: 14.710

Review 10.  Targetable pathogenic mechanisms in nasal polyposis.

Authors:  Alexander L Schneider; Robert P Schleimer; Bruce K Tan
Journal:  Int Forum Allergy Rhinol       Date:  2021-03-03       Impact factor: 5.426
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.